An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH-Mutant Lower-Grade Gliomas.
Gang XiaoXuan GaoLifeng LiChao LiuZhiyuan LiuHaiqin PengXuefeng XiaXin YiRongrong ZhouPublished in: Journal of oncology (2021)
-mutant gliomas, classifying patients into two subtypes with distinct immunophenotypes and overall survival.